Assessment of Compliance With Antihypertensive Telmisartan Therapy (COAST)
The purpose of this study is to asses the efficacy and safety of Telmisartan depending on the use of an electronic therapy monitoring device (HelpingHand) in a real life setting and to asses patients compliance to the therapy with Telmisartan in relation to use of electronic therapy monitoring device.
- Age over 18 - Untreated or ineffectively treated arterial hypertension
- Cholestatic disorders and severe hepatic failure - Allergy to Telmisartan - Pregnancy and lactation period - Unwillingness to participate in the study - Inability to use the drug reminder device - Unwillingness to use the drug reminder device
A Non-Interventional, Post-Marketing Surveillance, Phase IV Study to Assess Compliance With Antihypertensive Telmisartan Therapy